Sumitomo Mitsui Trust Group
HALO icon

Sumitomo Mitsui Trust Group’s Halozyme HALO Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$698K Buy
10,800
+2,300
+27% +$162K ﹤0.01% 893
2025
Q4 		$572K Buy
8,500
+4,100
+93% +$276K ﹤0.01% 930
2025
Q3 		$323K Buy
+4,400
New +$292K ﹤0.01% 1005

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group's HALO Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group increased its Halozyme (HALO) stake by 27% in Q1 2026, buying an estimated $162K and bringing the position to 10,800 shares worth $698K. The position accounts for ﹤0.01% of the portfolio, ranked #893.

Sumitomo Mitsui Trust Group first reported a position in HALO in Q3 2025 and has held it in 3 quarters since. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 10,800 shares of Halozyme worth $698K as of Q1 2026.
  • Sumitomo Mitsui Trust Group bought 2,300 Halozyme shares in Q1 2026, an estimated $162K.
  • Halozyme made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #893 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Halozyme in Q3 2025 and has held it in 3 quarters since.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.